Insider Purchases: Inside the Buy
Tag: Funanc1al
AngioDynamics (ANGO)’s CEO Bought Shares a Year Ago and Stock Doubled Since: Will They Keep Going Higher?
AngioDynamics insiders bought low and doubled up, while Wall Street funds practically own the company. With MedTech sales surging and earnings around the corner, can $ANGO climb higher — or will tariffs and volatility zap the gains?
CEO Bought Shares Higher A Year Ago. Will RH Restore Investor Confidence?
RH stock has crashed, but its CEO is still buying, funds are backing, and Paris is shining. With shorts circling and debt looming, is RH a comeback story—or just a fancy couch with shaky legs?
Insiders Think Marvell Is a Wonder at Current Price; Should You Emulate the CEO, CFO, and Presidents and Buy MRVL?
Insiders, buybacks, and AI growth — oh my! Marvell Technology’s execs just bought millions in stock. With a $5B buyback, should you marvel too?
CEO Bought Shares of Vertex Pharmaceuticals (VRTX) A Bit Higher Back in August: Great Biotech At A Fair Price. Wait For Additional Pull-Back?
Vertex is more than cystic fibrosis drugs. With gene editing, pain relief, and even a potential T1D cure, the CEO’s insider buy raises one question: buy now or wait for additional pullback?
Bill Ackman's Pershing Square Still Owns Shares; A Director Bought Much Higher: Should You Go Long Chipotle (CMG) Or Just Eat the Burritos?
Chipotle Mexican Grill (CMG) stock has been cut in half from its highs, but institutions still love it and Bill Ackman still owns a big stake. Should you wrap CMG in your portfolio—or just stick to wrapping burritos?
Keurig Dr Pepper (KDP) Insiders Have Been Buying Shares. What’s Brewing?
Insiders are brewing confidence in Keurig Dr Pepper (KDP) with fresh stock buys, while institutions are holding heavy. With a mega coffee deal, spinoff plans, and steady results, is this stock about to perk up or get watered down?
Can Freshpet Make for a Fresh Buy: Insiders & Directors Think So
Freshpet’s stock has tumbled more than 70% from its highs, but insiders keep buying and Wall Street funds are all-in (119% ownership!). With revenue growing, profitability improving, and valuation looking much more reasonable, is this the turnaround treat investors have been waiting for? 🐾🍖
Salesforce (CRM): Insider Buys, AI Clouds, and Customer Armies — Should You Join the Ride?
Salesforce insiders are buying, AI is booming, and institutions are all-in. But is CRM stock really ready to rebound — or just blowing more cloud smoke? ☁️💸
Revisiting Why MSCI’s CEO Bought Shares Multiple Times Over the Past Year
MSCI’s CEO has spent over $11M buying shares in the past year. With institutions holding nearly 95% and margins above 60%, is MSCI worth the premium?
Lyft’s CEO Keeps Buying Shares. Are They About to Lift Off?
Lyft’s CEO keeps buying stock while hedge funds pile in. With profits, free cash flow, and share buybacks, could LYFT finally lift off—or hit roadblocks? 🚗📈